BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.31% |
| 2 | Financials | 6.96% |
| 3 | Consumer Discretionary | 5.46% |
| 4 | Healthcare | 4.97% |
| 5 | Industrials | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
CALL
Weibo
WB
$1.88B
| $166K | ﹤0.01% |
37
| – | – |
|
2727
MBIA
MBI
$262M
| $164K | ﹤0.01% |
17,743
-9,771
| -36% | -$91.4K |
|
2728
Guardant Health
GH
$21.4B
| $164K | ﹤0.01% |
2,564
-332
| -11% | -$29.2K |
|
|
KEM
2729
DELISTED
KEMET Corporation
KEM
| $163K | ﹤0.01% |
8,993
-839
| -9% | -$15.8K |
|
2730
Standard Motor Products
SMP
$870M
| $163K | ﹤0.01% |
3,364
-221
| -6% | -$10.1K |
|
|
NBLX
2731
DELISTED
Noble Midstream Partners LP
NBLX
| $163K | ﹤0.01% |
6,769
+1,466
| +28% | +$40.8K |
|
|
CSW
2732
CSW Industrials
CSW
$5.59B
| $163K | ﹤0.01% |
2,360
+599
| +34% | +$41.4K |
|
|
CSR
2733
Centerspace
CSR
$939M
| $162K | ﹤0.01% |
2,176
-351
| -14% | -$23.5K |
|
2734
ePlus
PLUS
$2.31B
| $162K | ﹤0.01% |
4,254
+520
| +14% | +$20.1K |
|
2735
Enanta Pharmaceuticals
ENTA
$391M
| $162K | ﹤0.01% |
2,692
+816
| +43% | +$60.6K |
|
2736
Lantheus
LNTH
$6.59B
| $162K | ﹤0.01% |
6,450
+2,007
| +45% | +$49.4K |
|
2737
Veeco
VECO
$3.28B
| $162K | ﹤0.01% |
13,831
+4,034
| +41% | +$45.4K |
|
2738
Atlanta Braves Holdings Series B
BATRK
$3.41B
| $160K | ﹤0.01% |
5,779
+1,636
| +39% | +$46.2K |
|
|
OSG
2739
Octave Specialty Group
OSG
$212M
| $160K | ﹤0.01% |
8,199
-4,474
| -35% | -$82.2K |
|
2740
iShares MSCI Indonesia ETF
EIDO
$484M
| $160K | ﹤0.01% |
6,548
-486
| -7% | -$12.3K |
|
2741
Douglas Dynamics
PLOW
$967M
| $160K | ﹤0.01% |
3,592
+847
| +31% | +$35.5K |
|
2742
iShares MSCI Singapore ETF
EWS
$1.16B
| $160K | ﹤0.01% |
6,900
| – | – |
|
2743
Yeti Holdings
YETI
$3.44B
| $159K | ﹤0.01% |
5,692
+1,730
| +44% | +$52.5K |
|
2744
Amkor Technology
AMKR
$14.3B
| $159K | ﹤0.01% |
17,502
-5,884
| -25% | -$50.5K |
|
2745
Chunghwa Telecom
CHT
$32.8B
| $159K | ﹤0.01% |
4,462
-636
| -12% | -$22.4K |
|
|
FSP
2746
Franklin Street Properties
FSP
$46.4M
| $159K | ﹤0.01% |
18,803
-3,226
| -15% | -$25.3K |
|
|
TRHC
2747
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $159K | ﹤0.01% |
2,895
+810
| +39% | +$46.4K |
|
2748
Inogen
INGN
$154M
| $158K | ﹤0.01% |
3,305
+1,326
| +67% | +$69.2K |
|
2749
PUT
Nucor
NUE
$61.8B
| $158K | ﹤0.01% |
31
| – | – |
|
|
LMNX
2750
DELISTED
Luminex Corp
LMNX
| $157K | ﹤0.01% |
7,622
+1,983
| +35% | +$41.3K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.